Skip to main content

Table 1 Muscle dystrophy patients

From: Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy

Disease

Sample no.

Average of age ± SD (y.a.)

Sex (male/female)

Sporadic/Familial

Average of onset ± SD (y.a.)

Serum CK (U/ml)

DMD

5

10.4 ± 4.2

5/0

3/2

3.8 ± 1.1

9,101 ± 6,282

DMD

7

28.7 ± 1.5

7/0

7/0

3.8 ± 0.7

220 ± 126

DM1

8

59.4 ± 17.4

5/3

4/4

18.4 ± 16.9

121 ± 66

LGMD

7

50.0 ± 19.8

5/2

5/2

15.5 ± 13.9

633 ± 661

LGMAD2B

4

51.0 ± 18.2

3/1

4/0

23.0 ± 5.7

2,713 ± 2,722

FSHD

8

52.3 ± 17.3

4/4

4/4

14.4 ± 10.8

162 ± 155

BMD

4

52.0 ± 12.9

4/0

4/0

14 ± 14.6

687 ± 562

DMRV

5

39.2 ± 7.3

0/4

4/1

22.2 ± 6.2

206 ± 177

  1. y.a years of age